US Stock MarketDetailed Quotes

LXRX Lexicon Pharmaceuticals

Watchlist
  • 0.571
  • +0.223+64.13%
Close Mar 28 16:00 ET
  • 0.575
  • +0.004+0.77%
Post 20:01 ET
206.23MMarket Cap-0.91P/E (TTM)

Lexicon Pharmaceuticals Key Stats

Lexicon Pharmaceuticals Q4 2024 Earnings Date

Currency:USDMar 6, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
6.48M
26.55M
+20.07M
Beat Est.
+822.99%
+3682.62%
+309.82%
EPS
-0.12
-0.09
+0.03
Beat Est.
+41.02%
+55.00%
+23.66%
Buy

Mar 30, 2025

Lexicon Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.330M--
--2025/Q1-- / 1.263M--
Mar 6, 20252024/Q426.554M / 6.479M--
Nov 12, 20242024/Q31.750M / 2.929M--
Aug 1, 20242024/Q21.647M / 3.436M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.330M--
--2025/Q1-- / 1.263M--
Mar 6, 20252024/Q426.554M / 6.479M--
Nov 12, 20242024/Q31.750M / 2.929M--
Aug 1, 20242024/Q21.647M / 3.436M--

Unlock Free Earnings Estimates

Lexicon Pharmaceuticals Earnings Reports

Read more

Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 30, 2025

Buy

  • Buy

    33.33%
  • Hold

    66.67%
  • Sell

    0.00%

Price Target

No Data